of0
Export
 
CDE Detailed Report
This report contains detailed information about the selected CDEs.
Note: If at least one CDE was selected from a copyright- or trademark-protected instrument/scale then all of the CDEs from that instrument/scale are included in this report.
Disease: Spinal Cord Injury
SubDisease: Spinal Cord Injury
Sub-Domain: Neurological Outcomes
CRF: Tardieu Scale
Item count: 4 (4 distinct CDEs)
CDE ID
CDE Name
Variable Name
Definition / Description
Question Text
Permissible Value
Description
Data Type
Instructions
References
Population
Classification (e.g., Core)
Version #
Version Date
Aliases for Variable Name
CRF Module / Guideline
© or TM
Sub-Domain
Domain
Previous Title
Size
Input Restrictions
Min Value
Max Value
Measurement Type
LOINC ID
SNOMED
caDSR ID
CDISC ID
C11964
Tardieu Scale relative velocity rate
TardieuScaleRltvVelocRt
The relative velocity (for a repeated measure) during administration of the Tardieu Scale assessment to measure muscle reaction through evaluation of spasticity and resistance to passive limb movement in a participant/subject.
Velocity
1;2;3;
V1 - As slow as possible, slower than the natural drop of the limb segment under gravity;V2 - Speed of limb segment falling under gravity;V3 - As fast as possible, faster than the rate of the natural drop of the limb segment under gravity;
Numeric Values
Measurements take place at 3 velocities (V1, V2, and V3). Responses are recorded at each velocity as X/Y, with X indicating the 0 to 5 rating, and Y indicating the degree of angle at which the muscle reaction occurs.
Key Reference:
Tardieu G, Shentoub S, Delarue R. (1954) Research on a technic for measurement of spasticity. Rev Neurol (Paris), 91(2): 143–144.
Other References:
Ansari, N. N., Naghdi, S., Hasson, S., Azarsa, M. H., & Azarnia, S. (2008). The Modified Tardieu Scale for the measurement of elbow flexor spasticity in adult patients with hemiplegia. Brain Inj, 22(13-14), 1007–1012.
Boyd, R., & Graham, H. K. (1999). Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with CP. Eur J Neurol, 6(Suppol 4), S23–S35.
Gracies, J. M., Burke, K., Clegg, N. J., Browne, R., Rushing, C., Fehlings, D., . . . Delgado, M. R. (2010). Reliability of the Tardieu Scale for assessing spasticity in children with cerebral palsy. Arch Phys Med Rehabil, 91(3), 421–428.
Haugh AB, Pandyan AD, Johnson GR. (2006). A systematic review of the Tardieu Scale for the measurement of spasticity. Disabil Rehabil, 28(15): 899–907.
Morris, S. (2002). Ashworth And Tardieu Scales: Their Clinical Relevance For Measuring Spasticity In Adult And Paediatric Neurological Populations. Phys Ther Rev, 7(1), 53–62.
Adult;Pediatric
Exploratory
3.0
7/22/2013
Aliases for variable name not defined
Tardieu Scale
Neurological Outcomes
Outcomes and End Points
Tardieu Scale Q1
 
Single Pre-Defined Value Selected
       
C11965
Tardieu Scale movement resistance score
TardieuScaleMovmntResistScore
The semi-quantitative score describing relative resistance to passive limb movement or occurrence of spasticity observed while administering the Tardieu Scale assessment to measure the reaction of muscles of a tested limb in a participant/subject.
X
0;1;2;3;4;5;
No resistance throughout the course of the passive movement;Slight resistance throughout the course of passive movement, no clear catch at a precise angle;Clear catch at a precise angle, interrupting the passive movement, followed by release;Fatigable clonus with less than 10 seconds when maintaining the pressure and appearing at the precise angle;Unfatigable clonus with more than 10 seconds when maintaining the pressure and appearing at a precise angle;Joint is immovable (Indicate which assistive device the participant uses);
Numeric Values
Measurements take place at 3 velocities (V1, V2, and V3). Responses are recorded at each velocity as X/Y, with X indicating the 0 to 5 rating, and Y indicating the degree of angle at which the muscle reaction occurs.
Key Reference:
Tardieu G, Shentoub S, Delarue R. (1954) Research on a technic for measurement of spasticity. Rev Neurol (Paris), 91(2): 143–144.
Other References:
Ansari, N. N., Naghdi, S., Hasson, S., Azarsa, M. H., & Azarnia, S. (2008). The Modified Tardieu Scale for the measurement of elbow flexor spasticity in adult patients with hemiplegia. Brain Inj, 22(13-14), 1007–1012.
Boyd, R., & Graham, H. K. (1999). Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with CP. Eur J Neurol, 6(Suppol 4), S23–S35.
Gracies, J. M., Burke, K., Clegg, N. J., Browne, R., Rushing, C., Fehlings, D., . . . Delgado, M. R. (2010). Reliability of the Tardieu Scale for assessing spasticity in children with cerebral palsy. Arch Phys Med Rehabil, 91(3), 421–428.
Haugh AB, Pandyan AD, Johnson GR. (2006). A systematic review of the Tardieu Scale for the measurement of spasticity. Disabil Rehabil, 28(15): 899–907.
Morris, S. (2002). Ashworth And Tardieu Scales: Their Clinical Relevance For Measuring Spasticity In Adult And Paediatric Neurological Populations. Phys Ther Rev, 7(1), 53–62.
Adult;Pediatric
Exploratory
3.0
7/22/2013
Aliases for variable name not defined
Tardieu Scale
Neurological Outcomes
Outcomes and End Points
Tardieu Scale Q2
 
Single Pre-Defined Value Selected
       
C11966
Tardieu Scale muscle reaction angle measurement
TardieuScaleMuscReactAngMeasr
The degree of angle for limb position at which muscle reaction or spasticity occurs for a given velocity administered during the Tardieu Scale assessment to measure the reaction of muscles of a tested limb in a participant/subject.
Y (Degree of angle at which muscle reaction occurs)
  
Numeric Values
Measurements take place at 3 velocities (V1, V2, and V3). Responses are recorded at each velocity as X/Y, with X indicating the 0 to 5 rating, and Y indicating the degree of angle at which the muscle reaction occurs.
Key Reference:
Tardieu G, Shentoub S, Delarue R. (1954) Research on a technic for measurement of spasticity. Rev Neurol (Paris), 91(2): 143–144.
Other References:
Ansari, N. N., Naghdi, S., Hasson, S., Azarsa, M. H., & Azarnia, S. (2008). The Modified Tardieu Scale for the measurement of elbow flexor spasticity in adult patients with hemiplegia. Brain Inj, 22(13-14), 1007–1012.
Boyd, R., & Graham, H. K. (1999). Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with CP. Eur J Neurol, 6(Suppol 4), S23–S35.
Gracies, J. M., Burke, K., Clegg, N. J., Browne, R., Rushing, C., Fehlings, D., . . . Delgado, M. R. (2010). Reliability of the Tardieu Scale for assessing spasticity in children with cerebral palsy. Arch Phys Med Rehabil, 91(3), 421–428.
Haugh AB, Pandyan AD, Johnson GR. (2006). A systematic review of the Tardieu Scale for the measurement of spasticity. Disabil Rehabil, 28(15): 899–907.
Morris, S. (2002). Ashworth And Tardieu Scales: Their Clinical Relevance For Measuring Spasticity In Adult And Paediatric Neurological Populations. Phys Ther Rev, 7(1), 53–62.
Adult;Pediatric
Exploratory
3.0
7/22/2013
Aliases for variable name not defined
Tardieu Scale
Neurological Outcomes
Outcomes and End Points
Tardieu Scale Q3
 
Free-Form Entry
0
180
degree of arc
    
C17541
Tardieu Scale assistive device text
TardieuScaleAssistDevTxt
Text identifying an assistive device used by the participant/subject for an immovable joint in a limb.
Indicate which assistive device the participant uses
  
Alphanumeric
No instructions available
Key Reference:
Tardieu G, Shentoub S, Delarue R. (1954) Research on a technic for measurement of spasticity. Rev Neurol (Paris), 91(2): 143–144.
Other References:
Ansari, N. N., Naghdi, S., Hasson, S., Azarsa, M. H., & Azarnia, S. (2008). The Modified Tardieu Scale for the measurement of elbow flexor spasticity in adult patients with hemiplegia. Brain Inj, 22(13-14), 1007–1012.
Boyd, R., & Graham, H. K. (1999). Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with CP. Eur J Neurol, 6(Suppol 4), S23–S35.
Gracies, J. M., Burke, K., Clegg, N. J., Browne, R., Rushing, C., Fehlings, D., . . . Delgado, M. R. (2010). Reliability of the Tardieu Scale for assessing spasticity in children with cerebral palsy. Arch Phys Med Rehabil, 91(3), 421–428.
Haugh AB, Pandyan AD, Johnson GR. (2006). A systematic review of the Tardieu Scale for the measurement of spasticity. Disabil Rehabil, 28(15): 899–907.
Morris, S. (2002). Ashworth And Tardieu Scales: Their Clinical Relevance For Measuring Spasticity In Adult And Paediatric Neurological Populations. Phys Ther Rev, 7(1), 53–62.
Adult;Pediatric
Exploratory
3.0
7/15/2013
Aliases for variable name not defined
Tardieu Scale
Neurological Outcomes
Outcomes and End Points
 
255
Free-Form Entry
       
12-19-2018
Page 1 of 1